{"schema_version": 1, "id": "oklahoma-city-ok-msa/life-sciences/2026-10", "product": "Labor Market Pulse", "metro": {"geography_id": 314, "label": "Oklahoma City, OK MSA", "slug": "oklahoma-city-ok-msa"}, "focus_area": {"key": "life_sciences", "slug": "life-sciences", "label": "Life Sciences"}, "period": "2026-10", "public_after": "2026-10-01", "frozen_at": "2026-11-03T04:35:35.494348+00:00", "headline": "OKC clinical talent commands a premium as general hiring cools", "headline_summary": "Oklahoma City CRA pay ($119,914) runs 33% above the national median ($90,065) even as metro unemployment climbed to 3.70% from 3.40% a year ago.", "key_indicators": [{"label": "OKC MSA unemployment rate", "value": "3.70%", "context": "Up from 3.40% a year earlier (Sept. 2026)"}, {"label": "CRA advertised pay, metro vs. national", "value": "$119,914 vs $90,065", "context": "Metro runs ~33% above national median"}, {"label": "Oklahoma statewide unemployment", "value": "4.2%", "context": "Up from 3.6% a year ago; ranks 32nd nationally"}, {"label": "Biopharma active recruiting (national)", "value": "64%", "context": "Despite national quit rate of just 1.9%"}], "takeaways": [{"headline": "CRA pay premium in OKC outpaces the national market.", "body": "Metro median advertised pay for Clinical Research Associates ($119,914) runs roughly 33% above the national median ($90,065), consistent with national reporting that experienced CRAs remain the primary bottleneck in clinical operations. Employers budgeting against national benchmarks risk under-pricing this role locally and losing candidates to better-positioned bids."}, {"headline": "Regulatory affairs pay is softening locally and nationally at once.", "body": "Metro Regulatory Affairs Specialist pay fell to $82,162, trailing the national median of $103,780, which is itself down moderately. A simultaneous national and local decline suggests softening demand or a shift toward more junior hires as the likelier explanation for a metro-specific anomaly \u2014 worth confirming before assuming local scarcity justifies a pay premium."}, {"headline": "Biostatistician pay drop may signal a thinning local bench even as demand holds.", "body": "Metro median pay for biostatisticians fell to $142,734 \u2014 still above the stable national median of $131,958 \u2014 even as lab/R&D vacancy rates remain elevated nationally. A premium that is narrowing while still outpacing the national figure may signal employers filling roles at lower seniority levels even as competition for top talent persists."}, {"headline": "Workforce development pipelines are emerging as a hedge against hiring costs.", "body": "BioTC's non-degreed pathway into manufacturing and QA roles, paired with ARL's expansion, points to local employers building internal talent supply as a strategy to compete for CDMO and biomanufacturing staff alongside advertised pay increases. This may create an opportunity to blend workforce development partnerships with compensation strategy for harder-to-fill production and quality roles."}], "local_conditions": "Oklahoma City MSA unemployment rose to 3.70% in September 2026, up from 3.40% a year earlier, while statewide joblessness climbed to 4.2% \u2014 a sign that labor supply is loosening even as specialized technical hiring stays tight. Local biotech infrastructure investment continues alongside this slack, with ARL's expansion and the BioTC non-degreed training pipeline signaling an effort to build manufacturing and QA capacity from within as a complement to open-market pay.", "implications": "Metro-level slack in the broader labor market has not reached specialized scientific and clinical roles, where advertised pay for Clinical Research Associates ($119,914 local median) sits well above the national figure ($90,065), suggesting Oklahoma City employers are paying a premium to secure scarce clinical operations talent even as general hiring cools. Falling local pay for Regulatory Affairs Specialists and Biostatisticians points to softer demand or a thinner, more junior applicant pool clearing at lower rates \u2014 a pattern that complicates headcount planning across R&D, quality, and regulatory functions simultaneously. Consider reviewing role-by-role advertised pay trends, since CRA and lab technician roles are moving in the opposite direction from regulatory and biostatistics roles this month, which argues against treating life sciences compensation as a single category.", "looking_ahead": [{"category": "Worth watching", "body": "Oklahoma's statewide unemployment rise (3.6% to 4.2% year-over-year) has not yet shown up as a surge in life sciences-specific layoffs or WARN filings. Watch whether softening in adjacent sectors like energy or manufacturing begins feeding adjacent talent \u2014 lab techs, quality staff, engineers \u2014 into the life sciences candidate pool."}, {"category": "Emerging pressure point", "body": "Regulatory Affairs Specialist and Biostatistician advertised pay both moved down this month locally and nationally. Track whether this reflects demand softening or a shift in the mix of postings toward junior-level roles before adjusting compensation ranges downward."}, {"category": "Early indicator", "body": "ARL's expansion and continued CDMO/CRO investment in the metro could tighten competition for biomanufacturing and validation talent even as general unemployment rises. Validation Engineer pay has held stable ($81,749 local vs. $106,478 national) \u2014 a widening gap here would be an early signal of local undervaluation relative to specialized demand."}, {"category": "Potential inflection point", "body": "National quit rates remain low (1.9%) and 64% of biopharma organizations report active recruiting, per national research. If that national hiring momentum reaches Oklahoma City's CRO and CDMO base, expect faster movement in CRA and clinical data manager pay than the broader metro labor market would otherwise suggest."}], "roles": [{"role": "Research Scientist", "data_scope": "state_rollup", "metro_p25": 89932.0, "metro_p50": 109700.0, "metro_p75": 124723.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 130339.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Clinical Research Associate", "data_scope": "metro", "metro_p25": 69699.0, "metro_p50": 119914.0, "metro_p75": 124507.5, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 90065.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Lab Technician", "data_scope": "metro", "metro_p25": 37127.0, "metro_p50": 38480.0, "metro_p75": 40387.25, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 47840.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Regulatory Affairs Specialist", "data_scope": "metro", "metro_p25": 66242.0, "metro_p50": 82162.2, "metro_p75": 84479.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 103779.6, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Clinical Data Manager", "data_scope": "state_rollup", "metro_p25": 98522.5, "metro_p50": 106016.2, "metro_p75": 125923.25, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 123653.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Biostatistician", "data_scope": "metro", "metro_p25": 103189.0, "metro_p50": 142734.4, "metro_p75": 143050.0, "metro_trend_direction": "down", "metro_trend_magnitude": "significant", "national_p50": 131958.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Validation Engineer", "data_scope": "state_rollup", "metro_p25": 81749.0, "metro_p50": 81749.0, "metro_p75": 81749.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 106478.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}], "industry_snapshot": [], "citations": [{"source_name": "Bureau of Labor Statistics / MacroTrends", "source_url": null, "statement": "OKC MSA unemployment rose to 3.70% in September 2026 from 3.40% a year earlier"}, {"source_name": "Bureau of Labor Statistics", "source_url": null, "statement": "Oklahoma statewide unemployment reached 4.2%, ranking 32nd nationally"}, {"source_name": "Life sciences industry workforce research", "source_url": null, "statement": "Experienced CRAs remain the primary bottleneck in clinical operations hiring nationally"}, {"source_name": "Biopharma industry labor survey", "source_url": null, "statement": "64% of biopharma organizations actively recruiting despite 1.9% national quit rate"}, {"source_name": "Oklahoma life sciences industry reporting", "source_url": null, "statement": "ARL expansion and BioTC non-degreed training program in Oklahoma City Innovation District"}, {"source_name": "Bureau of Labor Statistics", "source_url": null, "statement": "Oklahoma statewide unemployment climbed from 3.6% to 4.2% year-over-year"}], "methodology": "Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay.", "edition_label": "November 2026", "files": {"html": "oklahoma-city-ok-msa/life-sciences/2026-10.html", "pdf": "oklahoma-city-ok-msa/life-sciences/2026-10.pdf"}, "published_at": "2026-11-03T08:27:37.081572+00:00", "report_html_url": "https://reports.wagescape.com/archive/v1/editions/oklahoma-city-ok-msa/life-sciences/2026-10.html", "report_pdf_url": "https://reports.wagescape.com/archive/v1/editions/oklahoma-city-ok-msa/life-sciences/2026-10.pdf"}